Janae Barnes
Senior Vice President of Investor Relations and Corporate Communications
Replay available
Atea Pharmaceuticals, Inc. (AVIR) Q4 2025 Earnings Call
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q4 2025 earnings conference call, held 2026-03-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. John-Pierre Sommadosi
Chief Executive Officer and Founder
Dr. Janet Hammond
Chief Development Officer
Dr. Aranjahorga
Chief Medical Officer
John Vavrica
Chief Commercial Officer
Andrea Porkrin
Chief Financial Officer and Executive Vice President of Legal
Jonathan Miller
Analyst, Evercore ISI
Andy Shea
Analyst, William Blair
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Atea Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0426a-7d76-7522-99a1-1870ff0f06f9 Created: 2026-08-27T08:51:11.929Z Duration: 2081.907 Channels: 1 00:00:00.000 -- 00:00:02.399 Good afternoon, everyone, and welcome to the Atea 00:00:02.399 -- 00:00:06.080 Pharmaceuticals Fourth Quarter twenty twenty five Financial Results 00:00:06.080 -- 00:00:08.160 and Business Update Conference Call. 00:00:08.480 -- 00:00:10.559 At this time, all participants are in a 00:00:10.559 -- 00:00:13.280 listen only mode. Following the formal remarks, we 00:00:13.280 -- 00:00:15.040 will open up the call for your questions. 00:00:15.724 -- 00:00:17.005 I would now like to turn the call 00:00:17.005 -- 00:00:19.724 over to Janae Barnes, Senior Vice President of 00:00:19.724 -- 00:00:23.564 Investor Relations and Corporate Communications at Atea Pharmaceuticals. 00:00:23.564 -- 00:00:25.005 Ms. Barnes, please proceed. 00:00:25.485 -- 00:00:28.445 Great. Thank you, operator. Good afternoon, everyone, and 00:00:28.445 -- 00:00:30.445 welcome to Atea Pharmaceuticals 00:00:30.190 -- 00:00:32.430 fourth quarter and full year twenty twenty five 00:00:32.430 -- 00:00:35.790 financial results and business update conference call. Earlier 00:00:35.790 -- 00:00:37.950 today, we issued a press release which outlines 00:00:37.950 -- 00:00:39.630 the topics we plan to discuss. 00:00:39.870 -- 00:00:41.710 You can access the press release as well 00:00:41.710 -- 00:00:43.710 as the slides that we'll be reviewing today 00:00:43.835 -- 00:00:45.915 by going to the Investors section of our 00:00:45.915 -- 00:00:49.195 website at ir.ateapharma.com. 00:00:49.355 -- 00:00:51.515 With me today from Atea are our Chief 00:00:51.515 -- 00:00:54.795 Executive Officer and Founder, Doctor. John Pierre Som...